AUS
NZ
UK
CA
USA
IND
Healthcare
-Copy_09_03_2024_14_56_33_467030.jpg)
Aptamer Renews Contract with Unilever
September 03, 2024 03:55 PM BST| By Team Kalkine MediaOn Tuesday, Aptamer,(LSE:APTA),, a company specializing in custom antibody alternatives, announced the extension of its contract with Unilever to advance the development of its Optimer asset for deodorant applications. This renewed agreement marks a...
Oxford Nanopore Shows Steady First Half Amid Market Challenges
September 03, 2024 11:54 AM BST| By Team Kalkine MediaOn Tuesday, Oxford Nanopore Technologies,(LSE:ONT),reported a steady performance for the first half of the year, despite facing challenging market conditions. For the six months ending June 30, the London-listed company's revenue reached £84.1 millio...
Aptamer Group Gains Boost from Unilever Collaboration Extension
September 03, 2024 11:21 AM BST| By Team Kalkine MediaShares of Aptamer Group PLC,(LSE:APTA),saw a 4% increase following the announcement of an extended contract with consumer giant Unilever PLC. The partnership focuses on advancing the development of Aptamer's Optimer binders, which are being designed...
Uniphar reports first-half growth in all its divisions
September 03, 2024 09:35 AM BST| By Team Kalkine MediaOn Tuesday, Uniphar,(LSE:UPR),, an international diversified healthcare service provider, reported robust first-half financial results, showcasing significant growth across all its divisions.,The AIM-traded company saw its revenue increase by 10.3%,...
Berenberg upgrades Hikma Pharmaceuticals
September 03, 2024 09:13 AM BST| By Team Kalkine MediaOn Tuesday, Berenberg upgraded Hikma Pharmaceuticals,(LSE:HIK),, raising the price target from 2,100p to 2,400p, citing significant progress within the company. After nearly two years of maintaining a neutral stance, Berenberg now sees it as an oppor...
Futura Medical Soars as Eroxon Launches in US Stores and Online in October
September 02, 2024 01:58 PM BST| By Team Kalkine MediaFutura Medical PLC,(LSE:FUM),has provided additional details regarding the US launch of its innovative erectile dysfunction gel, Eroxon, in collaboration with its major partner, Haleon PLC. As of September 1, the gel is available for pre-order online...
Roquefort Therapeutics Secures European Patent for MK Cell Therapy
September 02, 2024 01:38 PM BST| By Team Kalkine MediaRoquefort Therapeutics PLC, a company operating within the,Healthcare sector,, has achieved a significant milestone with the European Patent Office granting a patent for its Mesodermal Killer (MK) cell therapy. This patent provides intellectual prope...
Oncimmune Wins New Contract with Top Ten Global Pharma Company
September 02, 2024 01:14 PM BST| By Team Kalkine MediaOncimmune,(LSE:ONC),, a biotechnology firm, revealed on Monday that it has secured a significant new contract with a leading global pharmaceutical company, worth $700,000. This contract marks another step in the company's expansion and solidifies its...
GSK's RSV Vaccine Receives Expanded Approval in Europe
August 29, 2024 03:15 PM BST| By Team Kalkine MediaOn Thursday, GSK,(LSE:GSK),announced that the European Commission has approved its respiratory syncytial virus (RSV) vaccine, Arexvy, for use in adults aged 50 to 59 who are at increased risk of severe RSV-related illness. This approval marks the fir...
Totally Secures Multiple New Contracts and Extensions
August 29, 2024 02:37 PM BST| By Team Kalkine MediaOn Thursday, Totally,(LSE:TLY),, a healthcare services company, announced several new contracts and extensions in England and Ireland, with a total value estimated at approximately £4 million. These agreements mark a significant expansion of Totally’...
Ananda Developments Publishes Whitepaper on CBD Clinical Research Gap
August 29, 2024 01:13 PM BST| By Team Kalkine MediaAnanda Developments Plc has released a whitepaper detailing the potential therapeutic benefits and scope of cannabidiol (CBD). The document aims to address the significant gap in robust clinical data needed to fully assess CBD's efficacy and safety a...
Totally Shares Surge 10% After £1M New Business Win
August 29, 2024 01:02 PM BST| By Team Kalkine MediaShares of Totally PLC,(LSE:TLY),surged 10% following the announcement of several new contracts and extensions for its urgent and elective care services across England and Ireland.,The health and wellbeing group secured a notable insourcing contract t...
GSK Optimistic on Zantac Lawsuit and Japan Approvals
August 28, 2024 11:45 AM BST| By Team Kalkine MediaOn Wednesday, GSK,(LSE:GEK),announced several significant updates. The company welcomed a decision from the Delaware Supreme Court to review a lower court ruling that permitted the introduction of expert evidence in ongoing litigation related to its...
Polarean Appoints Xenon MRI Expert as Chief Medical Advisor
August 28, 2024 05:52 AM BST| By Team Kalkine MediaPolarean Imaging,(LSE:POLX),has announced the appointment of Dr. Chase Hall as its chief medical advisor. Dr. Hall, renowned for his expertise in pulmonary, critical care, and sleep medicine, is set to enhance the company's capabilities in respirator...
-Copy_08_27_2024_15_08_59_207354.jpg)
Diaceutics Reports Advancements in Rare-Disease Offerings
August 27, 2024 04:08 PM BST| By Team Kalkine MediaDiaceutics,(LSE:DXRX),announced a major enhancement to its rare-disease offerings on Tuesday, marked by the acquisition of a new contract designed to support the commercialization of a therapy for rare diseases.,The AIM-listed company revealed that t...
Belluscura Shares Surge on Strong Sales and Improved Outlook
August 27, 2024 04:07 PM BST| By Team Kalkine MediaBelluscura,(LSE:BELL),, known for its development of lightweight and portable oxygen enrichment technology, reported significant sales growth and an optimistic trading outlook on Tuesday as it geared up for the full commercial launch of its new DISCO...
Faron Pharmaceuticals Gains US Fast-Track Approval for Bexmarilimab
August 27, 2024 03:04 PM BST| By Team Kalkine MediaFaron Pharmaceuticals Limited,(LSE:FARN),has received fast-track approval from the US Food and Drug Administration (FDA) for its leading drug candidate, bexmarilimab, intended to treat relapsed or refractory myelodysplastic syndrome (r/r MDS) in comb...
Shield Therapeutics Shares Rise 7% After Canada Approval
August 27, 2024 12:00 AM BST| By Team Kalkine MediaShares in Shield Therapeutics PLC,(LSE:STX),saw a 7% rise in early trading following the approval of its drug, Accrufer (ferric maltol), by Health Canada for the treatment of iron deficiency anaemia (IDA) in adults. This significant regulatory approv...
AstraZeneca May Shift UK Vaccine Production to the US
August 23, 2024 03:28 PM BST| By Team Kalkine MediaAstraZeneca,(LSE:AZN),has indicated that it might relocate its vaccine manufacturing operations from the UK to the United States if ongoing discussions with the new Labour government over state aid cuts remain unresolved, according to a report by the...
GSK (LSE:GSK) Receives US FDA Breakthrough Therapy Designation for B7-H3-Targeted ADC in Relapsed Extensive-Stage Small-Cell Lung Cancer
August 20, 2024 08:48 AM BST| By Team Kalkine MediaGSK plc (LSE/NYSE:GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to GSK5764227 (GSK'227), the Company’s investigational B7-H3-targeted antibody-drug conjugate (ADC). This designation i...
